Grapefruit USA Inc (GPFT)

[ElHefe]

This post could be anticipated from someone, it was inevitable. Dean's commentary on the increased authorized share count has been on the record in previous CCs for months, simply refer back to them if a review is desired. Even without this proposed change, they've had room to increase the actual share count by 150 million or so for the past year. Dean has stated repeatedly they have no plans to increase the share count. Again, we find ourselves in "believe him" or "don't believe him" territory. Do as one likes. I don't see what's to be gained from incessantly covering the same ground over and over again on this as well as other subjects.

Don't take eyes off the ball, there's only one thing that matters here. This is not a production play, it's not gonna happen. This is not a move to a bigger board play, not gonna happen. Company financials are those of a development stage outfit and will remain so until approval or BK. Company valuation is not predicated on current P&L, revs from C-arm remanufactures, cash on hand, etc. It's about IP, the extent to which the value of that IP is enhanced by FDA approval, and how much that FDA approved IP will be valued at when integrated over the markets of large imaging manufacturers. It's about FDA now. Period.